Budget Impact of Switching to Biosimilar Trastuzumab (CT-P6) for the Treatment of Breast Cancer and Gastric Cancer in 28 European Countries - Concepedia

Concepedia

Publication | Closed Access

Budget Impact of Switching to Biosimilar Trastuzumab (CT-P6) for the Treatment of Breast Cancer and Gastric Cancer in 28 European Countries

39

Citations

52

References

2019

Year

Seung-Mi Lee, Jae‐Ho Jung, David Suh, Seung-Lai Yoo, Dong-Won Kim, Ji-An Kim, Dong‐Churl Suh

OncologyCancer ManagementBudget ImpactBreast CancerSurgeryGastric CancerCancer TreatmentMedicineRadiation OncologyCancer Research

References

	Year	Citations

Page 1